These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 20623774)
1. Direct and indirect pathways in levodopa-induced dyskinesia: a more complex matter than a network imbalance. Ghiglieri V; Picconi B; Calabresi P Mov Disord; 2010 Aug; 25(11):1527-9. PubMed ID: 20623774 [No Abstract] [Full Text] [Related]
2. [Long-term complications of treatment with levodopa]. Castro García A; Sesar Ignacio A Neurologia; 1998; 13 Suppl 1():41-8. PubMed ID: 9859685 [No Abstract] [Full Text] [Related]
3. Ropinirole as compared with levodopa in Parkinson's disease. Weiner WJ; Factor SA N Engl J Med; 2000 Sep; 343(12):885. PubMed ID: 11001687 [No Abstract] [Full Text] [Related]
4. Ropinirole as compared with levodopa in Parkinson's disease. Frucht S N Engl J Med; 2000 Sep; 343(12):885. PubMed ID: 11001686 [No Abstract] [Full Text] [Related]
5. Ropinirole as compared with levodopa in Parkinson's disease. Yamamoto T N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001685 [No Abstract] [Full Text] [Related]
7. Pathophysiology of levodopa-induced dyskinesia: potential for new therapies. Bezard E; Brotchie JM; Gross CE Nat Rev Neurosci; 2001 Aug; 2(8):577-88. PubMed ID: 11484001 [TBL] [Abstract][Full Text] [Related]
8. Levodopa in the treatment of Parkinson's disease: current controversies. Gerlach M; Reichmann H; Riederer P Mov Disord; 2005 May; 20(5):643; author reply 643-4. PubMed ID: 15732130 [No Abstract] [Full Text] [Related]
9. Ropinirole as compared with levodopa in Parkinson's disease. Hiner BC; Earnhart M N Engl J Med; 2000 Sep; 343(12):884; author reply 885. PubMed ID: 11001684 [No Abstract] [Full Text] [Related]
10. Current controversies: levodopa in the treatment of Parkinson's disease. Sharma JC; Vassallo M; Ross IN Mov Disord; 2005 May; 20(5):642-3; author reply 643-4. PubMed ID: 15732129 [No Abstract] [Full Text] [Related]
11. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Vidailhet M; Bonnet AM; Marconi R; Durif F; Agid Y Mov Disord; 1999; 14 Suppl 1():13-8. PubMed ID: 10493399 [No Abstract] [Full Text] [Related]
15. Serpentine tongue: A rare manifestation following initiation of levodopa therapy in a patient with Parkinson's disease. Prashantha DK; Pal PK Parkinsonism Relat Disord; 2009 Nov; 15(9):718-9. PubMed ID: 19157953 [No Abstract] [Full Text] [Related]